clinical trial · NCT03749317
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
Adenoviral ConjunctivitisIVIEW-1201Placebo
brief summary
A Phase 2, Multi-center, Randomized, Double-Masked Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Placebo in the Treatment of Adenoviral Conjunctivitis
started
Feb 20, 2023
primary completion
Apr 30, 2024
completion
Dec 31, 2024
last updated
Oct 15, 2025
official title
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral Conjunctivitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol